You are here

Fast Track Designation Granted for Cloretazine in Elderly Poor-Risk Acute Myelogenous Leukemia

NEW HAVEN, Conn., Oct. 17 /PRNewswire-FirstCall/ -- Vion Pharmaceuticals, Inc. (NASDAQ:VION) announced today that it had received Fast Track designation from the U.S. Food and Drug Administration ("FDA") for its anticancer agent Cloretazine(R) for induction treatment of patients over 60 years of age with poor-risk acute myelogenous leukemia ("AML"). This is the second indication for which Cloretazine(R) has received a Fast Track designation.

Under the FDA Modernization Act of 1997, Fast Track designation allows the FDA to accept, on a rolling basis, portions of a marketing application prior to the completion of the final registration package. Fast Track designation may potentially expedite the review of a drug that is intended for the treatment of a serious life-threatening condition and demonstrates the potential to address an unmet medical need for such a condition.

Alan Kessman, Chief Executive Officer, stated, "We are pleased that the FDA has granted an additional fast track designation to Cloretazine(R). Based on our Phase II data in this indication, we believe that Cloretazine(R) has potential for the treatment of this unmet medical need. We look forward to meeting with the FDA to discuss the specifics of the path forward."

Source: Vion Pharmaceuticals, Inc.

Recent Headlines

Scenesse is new treatment for people with rare, painful light sensitivity disease
Humira, Rituxan top list of drugs that added $5.1 billion to nation's health care bill
Lower court rulings cleared the way for generic versions of the MS drug
Maryland man wins lawsuit that alleges that the company's antipsychotic caused his gynecomastia
Antidepressants, ADHD meds are also used to self-poison
Study lists steps that could save close to $300 billion a year
While many victims used THC, the cause remains elusive
Descovy joins Truvada, another Gilead product, in the HIV prophylaxis market
Data show PTC Therapeutics drug preserves lung function